In vitro and in vivo effects of a nutrient mixture on breast cancer progression

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 1933-1944

  Roomi, M W ^a   Kalinovsky, T ^a   Roomi, N M ^a   Cha, J ^a   Rath, M ^a   Niedzwiecki, Aleksandra ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

Breast cancer 4T1 cell line; Matrigel invasion; Metastasis; Migration; MMPs; Nutrients; Tumor growth

Indexed keywords

ASCORBIC ACID; GELATINASE A; GELATINASE B; GREEN TEA EXTRACT; LYSINE; MATRIGEL; PROLINE; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER GROWTH; CANCER SIZE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIGITAL CALIPER; FEMALE; HEART METASTASIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY METASTASIS; LIVER HISTOLOGY; LIVER METASTASIS; LUNG METASTASIS; MOUSE; MTT ASSAY; NONHUMAN; NUTRIENT; NUTRIENT MIXTURE; PRIORITY JOURNAL; PROTEIN SECRETION; SPLEEN METASTASIS; TUMOR VOLUME; ZYMOGRAPHY; ANIMAL TISSUE; BREAST CANCER CELL LINE; CANCER SURVIVAL; CELL STRUCTURE; HISTOPATHOLOGY; LONG TERM SURVIVAL; TUMOR NECROSIS; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; DIET THERAPY; EXPERIMENTAL MAMMARY NEOPLASM; HUMAN; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; TUMOR BURDEN;

EID: 84899530365     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2379     Document Type: Article

References (38)

1. American Cancer Society: Breast cancer: what are the key statistics about breast cancer? http://www.cancer.org/cancer/breastcancer/detailedguide/breast- cancer-key-statistics). Accessed 10/9/13. Last Medical Review: 09/11/2013. Last Revised: 10/01/2013.
2. Ali SM, Harvey HA and Lipton A: Metastatic breast cancer: overview of treatment. Clin Orthop 414 (Suppl): 132-137, 2003.
3. Fidler IJ: Molecular biology of cancer: invasion and metastasis In: Cancer: Principles and Practice of Oncology 5th edition. De Vita VT, Hellman S and Rosenberg SA (eds). Lippincott-Raven, Philadelphia, PA, pp135-152, 1997.
4. Rath M and Pauling L: Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs. Orthomolecular Med 7: 17-23, 1992.
5. Niedzwiecki A, Roomi MW, Kalinovsky T and Rath M: Micronutrient synergy - a new tool in effective control of metastasis and other key mechanisms of cancer. Cancer Metastasis Rev 29: 529-543, 2010.
6. Bibby MC: Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40: 852-857, 2004.
7. Eccles SA, Box G, Court W, Sandle J and Dean CJ: Preclinical models for the evaluation of targeted therapies of metastatic disease. Cell Biophys 24-25: 279-291, 1994.
8. Hoffman RM: Orthotopic metastatic mouse models for anti-cancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359, 1999.
9. Vernon E, Bakewell SJ and Chodash LA: Deciphering the molecular basis of breast cancer metastasis with mouse models. Rev Endocr Metab Disord 8: 199-213, 2007.
10. Tao K, Fang M, Aloy J and Sahagian GG: Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8: 228, 2008.
11. Aslakson CJ and Miller FR: Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 1399-1405, 1992.
12. Bonfil RD, Bustuabad OD, Ruggiero RA, Meiss RP and Pasqualini CD: Tumor necrosis can facilitate the appearance of metastases. Clin Exp Metastasis 6: 121-129, 1988.
13. Bonfil RD, Medina PA, Gómez DE, Farías E, Lazarowski A, Lucero Gritti MF, Meiss RP and Bustuabad OD: Expression of gelatinase/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion. Clin Exp Metastasis 10: 211-220, 1992.
14. Cha J, Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A and Rath M: Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C deficient mice. Int J Oncol 42: 55-64, 2013.
15. Bachmeier BE, Nerlich AG, Lichtinghagen R and Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 6A: 3821-3828, 2001.
16. Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ and Kosma VM: Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER-2, and prognosis. Clin Cancer Res 10: 7621-7628, 2004.
17. Connolly EM, Harmey JH O'Grady T, Foley D, Roche-Nagle G, Kay E and Bouchier-Hayes DJ: Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. Br J Cancer 87: 231-237, 2002.
18. Denardo DG, Johansson M and Coussans LM: Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 27: 11-18, 2008.
19. van Kempen LC, de Visser KE and Coussens LM: Inflammation, proteases and cancer. Eur J Cancer 42: 728-734, 2006.
20. Roomi MW, Kalinovsky T, Roomi NW, Rath M and Niedzwiecki A: Inhibition of growth and expression of inflammation mediators in human leukemic cell line. Exp Oncol 35: 180-186, 2013.
21. Roomi MW, Kalinovsky T, Niedzwiecki A and Rath M: Pleiotropic effects of a micronutrient mixture on critical parameters of bladder cancer. In: Bladder Cancer Etymology, Diagnosis and Treatments. Nilsson WE (ed). Nova Science Publishers, Inc., New York, 2009.
22. Sun Z, Chen YH, Wang P, Zhang J, Gurewich V, Zhang P and Liu JN: The blockage of high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. Biochem Biophys Acta 1596: 182-192, 2002.
23. Valcic S, Timmermann BN, Alberts DS, Wachter GA, Krutzsch M, Wymer J and Guillen JM: Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 7: 461-468, 1996.
24. Mukhtar H and Ahmed N: Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71: S1698-S1702, 2000.
25. Yang GY, Liao J, Kim K, Yurtow EJ and Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19: 611-616, 1998.
26. Taniguchi S, Fujiki H, Kobayashi H, Go H, Miyado K, Sadano H and Shimikawa R: Effect of (-) epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 65: 51-54, 1992.
27. Hara Y: Green tea: Health Benefits and Applications. Marcel Dekker, New York, Basel, 2001.
28. Kawakami S, Kageyama Y, Fujii Y, Kihara K and Oshima H: Inhibitory effects of N-acetyl cysteine on invasion and MMP 9 production of T24 human bladder cancer cells. Anticancer Res 21: 213-219, 2001.
29. Morini M, Cai T, Aluigi MG, Noonan DM, Masiello L, De Floro S, D'Agostinin F, Albini A and Fassima G: The role of the thiol N-acetyl cysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers 14: 268-271, 1999.
30. Yoon SO, Kim MM and Chung AS: Inhibitory effects of selenite on invasion of HT 1080 tumor cells. J Biol Chem 276: 20085-20092, 2001.
31. Naidu KA, Karl RC and Coppola D: Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor. Dig Dis Sci 48: 230-237, 2003.
32. Anthony HM and Schorah CJ: Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 46: 354-367, 1982.
33. Maramag C, Menon M, Balaji KC, Reddy PG and Laxmanan S: Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability and DNA synthesis. Prostate 32: 188-195, 1997.
34. Koh WS, Lee SJ, Lee H, Park C, Park MH, Kim WS, Yoon SS, Park K, Hong SI, Chung MH and Park CH: Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res 8: 2487-2493, 1998.
35. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E and Levine M: Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 102: 13604-13609, 2005.
36. Nunez C, Ortiz de Apodaca Y and Ruiz A: Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of consumption of food with an elevated content of this vitamin. Nutr Hosp 10: 368-372, 1995.
37. Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D and Bruckner HW: Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 103: 183-189, 1996.
38. Cooke JP and Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48: 489-509, 1997.